Combination Therapy for Chronic Lymphoid Leukemia
نویسندگان
چکیده
منابع مشابه
Combination Therapy for Chronic Lymphoid Leukemia
For decades, the treatment of chronic lymphocytic leukemia (CLL) has relied on cytotoxic drugs with incremental benefit from anti-CD20 monoclonal antibodies. However, in the past 5 years, targeted drugs have fundamentally changed the management and outcome of CLL [1-3]. These new drugs are the result of improvements in our understanding of the pathogenesis of CLL, culminating in the development...
متن کاملCombination therapy for chronic migraine
Neurology 2012;78:940–941 Chronic migraine (CM) is a frequent and challenging condition for practicing neurologists. It affects around 2% of adults and its prevalence in middleaged women reaches 5%.1 Management of CM is generally unsatisfactory and largely not evidencebased, in part because until recently CM has not been considered a true entity, but mostly a consequence of analgesic overuse. E...
متن کاملParaneoplastic leukocytoclastic vasculitis in chronic lymphoid leukemia.
A 50-year-old female who was a known case of chronic lymphoid leukemia (CLL) developed ecchymoses, purpuric spots with papules, some nodules (1-3 mm) and crusts all over the body associated with severe burning and itching along with exaggeration of CLL. The lesions were more prominent on lower limbs and face. Skin biopsy was reported as leukocytoclastic vasculitis. These lesions regressed after...
متن کاملSpecies-specific therapy of acute lymphoid leukemia.
In the past 10 years immunophenotyping of ALL has been demonstrated to be useful for selecting and scheduling chemotherapy. Different drug regimens are now used for T-cell and B-cell ALL than for non-T non-B ALL with the result that survival and cure of T-cell and B-cell ALL have been considerably improved. The use of different drug regimens for different immunophenotypic varieties of non-T non...
متن کاملEFFICACY AND SAFETY OF COMBINATION THERAPY OF INTERFERON-ALPHA 2B PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C
Introduction: The aim of this study is to assess the therapeutic efficacy and safety of a particular brand of IFN alpha (PDferon B®) in combination with ribavirin (RlBA) on Iranian patients with chronic hepatitis C (CHC). The addition of RIBA to the standard treatment with interferon (IFN) alpha led to an improvement in sustained virologic response (SVR) from less than 20% with IFN monother...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cancer Science & Therapy
سال: 2016
ISSN: 1948-5956
DOI: 10.4172/1948-5956.1000395